Glutathione (GSH) improved haemostatic and haemorheological parameters in atherosclerotic subjects

Drugs Exp Clin Res. 1992;18(11-12):493-8.


Blood samples from ten patients with clinically evident manifestations of atherosclerotic disease were used to evaluate in vitro the effects of exogenous glutathione (GSH) on platelet aggregation and on blood filtration and viscosity. In two groups, each of ten atherosclerotic patients, matched for sex, age, prevalent localization, duration and gravity of disease, the effects of GSH infusion (600 mg every day for seven days) on the haemocoagulative pattern, platelet aggregation and blood filtration and viscosity were evaluated in a double-blind, placebo cross-over trial. The GSH in vitro addition resulted in a significant increase in blood filtration and a significant decrease in blood viscosity and platelet aggregation. The venous GSH infusion both significantly decreased blood viscosity and increased blood filtration. Partial thromboplastin time was lengthened after GSH infusion even thought it remained in the normal range.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Arteriosclerosis / blood
  • Arteriosclerosis / drug therapy*
  • Female
  • Glutathione / administration & dosage
  • Glutathione / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Male
  • Platelet Aggregation / drug effects
  • Viscosity / drug effects


  • Glutathione